Nye medlemmer
New company member: Stallergenes Greer
The Danish French Chamber of Commerce is proud to present a brand-new company member: Stallergenes Greer.
Approximately 30% of the world population is affected by one or more allergic conditions, and it is expected that by 2050, several billion people will suffer from allergies – a true chronic disease with a significant impact on the quality of life.
Stallergenes Greer is a global biopharmaceutical company specialising in the research, diagnosis, and treatment of those allergies through the development and commercialisation of allergen immunotherapy (also called “AIT”) products and services. The company’s head office and main production site are located near Paris, in France.
Because patients deserve an allergen immunotherapy solution that is tailored to their needs and profile, we are pushing the boundaries of science to fully leverage the potential of precision medicine. We develop advanced diagnostic tools
and AIT treatments which allow to both identify the patients most likely to benefit significantly from AIT and to choose the appropriate treatment for them. Our extensive product portfolio and precise personalized treatment solutions provide innovative patient care which meets the needs of both individual patient profiles and the medical community.
Stallergenes Greer is a private company which globally employs more than 1 100 people and is active, directly or indirectly, in more than 60 countries. And starting from 2024, Stallergenes Greer enters the Nordic region with a brand new regional office located in Copenhagen.
More information on our website: https://www.stallergenesgreer.com/
